RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Canadian guidelines issued on managing #opioid use disorders https://t.co/yLBcHjp5t3 @CMAJ
New clinical guideline for opioid addiction treatment via@cmaj #OpioidEpidemic #addiction #oud #buprenorphine #naloxone https://t.co/wEU6m5JbFa
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @RJmdphilly: @PEMammen @TJUHospital @theEDpharmacist @JeffIMchiefs Here’s the link to the full statement. Many recs with strong evidenc…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
Management of opioid use disorders: a national clinical practice guideline, via @CMAJ https://t.co/ulzFjdtHhJ #opioidcrisis #opioids
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @theresaboyle: Management of opioid use disorders: a national clinical practice guideline - CMAJ https://t.co/q7SfoJPuyg via @nuzzel tha…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
At least the Canadians offer alternatives... https://t.co/xx0zkkNYVd
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
Manejo de los trastornos por uso de #opioides: una guía nacional de práctica clínica https://t.co/0Fn0ekMxMK
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @picardonhealth: New clinical practice guideline on management of #opioids use disorders. https://t.co/Wu1QFXsiJC via @CMAJ https://t.co…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @LNelsonMD: Management of opioid use disorders: a national clinical practice guideline | CMAJ https://t.co/Wbp8dkolK7
RT @drcwg: Love the new Canadian guidelines on treating opiate use disorder - easy-to-use - now if we can just expand access! #primarycare…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @adfoxMD: Canadian guidelines for management of Opioid Use Disorder. Interesting differences from US: endorse slow-release oral morphine…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Management of opioid use disorders: a national clinical practice guideline | CMAJ https://t.co/Wbp8dkolK7
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @joshuarosenowMD: With more and more guidelines for #opioid use coming out we must make sure that we do not get confused by differing re…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @FarmaciaOesteAP: (CMAJ) GPC sobre manejo del abuso de opioides https://t.co/To8Pb622RS
RT @KathyReid5: Clinical practice guidelines for management of opioid use disorders. Important info here for NPs @AlbertaNPs https://t.co/1…
RT @CrismCan: LISTEN: Drs. Evan Wood, @KeithAhamad, Julie Bruneau and @DreGoyer on @CMAJ podcasts discussing the new #opioid guideline http…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @picardonhealth: New clinical practice guideline on management of #opioids use disorders. https://t.co/Wu1QFXsiJC via @CMAJ https://t.co…
With more and more guidelines for #opioid use coming out we must make sure that we do not get confused by differing recommendations. #EBM must be used with modicum of clinical judgment for each patient. #consensus recommendations not as powerful. #OpiodC
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @NurseNerdy: New practice guideline! By @CMAJ - Management of opioid use disorders: a national clinical practice guideline #cdnhealth…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
Clinical practice guidelines for management of opioid use disorders. Important info here for NPs @AlbertaNPs https://t.co/1bMD2KXLh8
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @picardonhealth: New clinical practice guideline on management of #opioids use disorders. https://t.co/Wu1QFXsiJC via @CMAJ https://t.co…
RT @MyHarmReduction: Would love to see something like this in the US! Love the fact that naltrexone is at the absolute bottom and agonist t…
Would love to see something like this in the US! Love the fact that naltrexone is at the absolute bottom and agonist treatments are best. #harmreduction https://t.co/dGvktQQEK7
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Opioid use disorder is a chronic disease and should be managed that way. #suboxone is first line. https://t.co/IslDThGwEd
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
Management of opioid use disorders: a national clinical practice guideline - CMAJ https://t.co/q7SfoJPuyg via @nuzzel thanks @JustSayIt_MD
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…